Showing results (211-220 of 254) with videos related to

Sort By:
Pageof 26
Marine Drugs|May 28, 2020
Quorum Sensing Inhibitory and Antifouling Activities of New Bromotyrosine Metabolites from the Polynesian Sponge Pseudoceratina n. spFlorent Tintillier, Céline Moriou, Sylvain Petek, et al.
Molecular Phylogenetics and Evolution|March 13, 2012
Horny sponges and their affairs: on the phylogenetic relationships of keratose spongesDirk Erpenbeck, Patricia Sutcliffe, Steve de C Cook, et al.
Iscience|November 19, 2018
Perovskite Photovoltaic Modules: Life Cycle Assessment of Pre-industrial Production ProcessJaume-Adrià Alberola-Borràs, Jenny A Baker, Francesca De Rossi, et al.
The International Journal of Eating Disorders|February 14, 2024
Differentiation between atypical anorexia nervosa and anorexia nervosa using machine learningLuis E Sandoval-Araujo, Claire E Cusack, Christina Ralph-Nearman, et al.
Molecular Phylogenetics and Evolution|August 15, 2025
Target-enriched multilocus assay on poriferan museum collections unsettles tethyid classificationDirk Erpenbeck, Fabian Deister, Merrick Ekins, et al.
Chemistry & Biodiversity|August 18, 2012
New antiplasmodial bromotyrosine derivatives from Suberea ianthelliformis Lendenfeld, 1888Luke Mani, Valerie Jullian, Beatrice Mourkazel, et al.
The International Journal of Biochemistry & Cell Biology|January 15, 2008
Gender specific effects on the actin-remodelling protein Flightless I and TGF-beta1 contribute to impaired wound healing in aged skinDamian H Adams, Xanthe L Strudwick, Zlatko Kopecki, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignanciesRenata E Zaucha, Dean C Buckner, Todd Barnett, et al.
The Journal of Organic Chemistry|April 21, 2010
Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Theonella speciesAlberto Plaza, Giuseppe Bifulco, Milena Masullo, et al.
Cancer Research|January 13, 2001
Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasisF Liao, Y Li, W O'Connor, et al.
Pageof 26